MedPath

Study to Determine Racial and Gender Differences in Platelet Aggregation

Completed
Conditions
Platelet Aggregation
Registration Number
NCT00233428
Lead Sponsor
Texas Tech University Health Sciences Center
Brief Summary

The purpose of this study is to see if there is a racial and/or gender difference in platelet aggregation.

Detailed Description

Genetic variability of various components of the coagulation system has been reported. Data on racial and gender differences in platelet aggregation are lacking.

We hypothesize that there are significant racial and gender differences on aggregatory response of platelets to commonly used agonists to evaluate platelet function such as adenosine diphosphate (ADP), epinephrine, collagen and arachidonic acid.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Race of Caucasian, African American, or Hispanic
Exclusion Criteria
  • Chronic medical conditions
  • Tobacco use
  • Regular non-steroidal anti-inflammatory use, aspirin use, or use of one of the other anti-platelet drugs.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

TTUHSC

🇺🇸

Lubbock, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath